Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 3—March 2020
CME ACTIVITY - Synopsis

Epidemiology of Cryptosporidiosis, New York City, New York, USA, 1995–20181

Lisa Alleyne, Robert Fitzhenry, Kimberly A. Mergen, Noel Espina, Erlinda Amoroso, Daniel Cimini, Sharon Balter2, Ana Maria Fireteanu, Anne Seeley, Lorraine Janus, Bruce Gutelius3, Susan Madison-Antenucci, and Corinne N. ThompsonComments to Author 
Author affiliations: New York City Department Health and Mental Hygiene, Long Island City, New York, USA (L. Alleyne, R. Fitzhenry, E. Amoroso, D. Cimini, S. Balter, A.M. Fireteanu, B. Gutelius, C.N. Thompson); New York State Department of Health, Albany, New York, USA (K.A. Mergen, N. Espina, S. Madison-Antenucci); New York City Department of Environmental Protection, Corona, New York, USA (A. Seeley, L. Janus)

Main Article

Table 1

Descriptive epidemiology of cryptosporidiosis in New York City, New York, USA, 2000–2014 and 2015–2018*

Category 2000–2014
 2015–2018
No. cases Incidence IRR (95% CI) No. cases Incidence IRR (95% CI)
No. cases
 3,244
 1.46
740
 2.11
Age group, y†
<5 261 2.30 1.05 (0.83–1.32) 78 3.13 1.11 (0.76–1.60)
5–9 149 1.26 0.65 (0.50–0.85) 34 1.75 0.55 (0.35–0.86)
10–19 170 0.75 0.37 (0.29–0.48) 57 1.44 0.49 (0.33–0.73)
20–44 1,827 2.17 Referent 413 3.13 Referent
45–59 580 1.41 0.70 (0.57–0.86) 107 1.70 0.52 (0.36–0.74)
>59
 254
 0.39
 0.22 (0.17–0.29)
51
 0.69
 0.24 (0.16–0.36)
Sex
M 2,230 2.00 2.06 (1.70–2.49) 484 2.71 1.82 (1.34–2.48)
F
 1,014
 0.80
 Referent
255
 1.60
 Referent
Sex and age group, y†
All <20 580 1.26 0.43 (0.35–0.52) 169 2.19 0.57 (0.39–0.84)
Men 20–59 1,789 2.96 Referent 355 3.55 Referent
Men >59 135 0.60 0.22 (0.16–0.30) 33 1.06 0.30 (0.19–0.50)
Women >20
 737
 0.74
 0.24 (0.20–0.30)
182
 1.43
 0.34 (0.23–0.51)
Borough of residence
Bronx 583 1.59 0.57 (0.48–0.68) 129 2.09 0.54 (0.38–0.75)
Brooklyn 642 1.11 0.34 (0.28–0.40) 186 1.48 0.39 (0.28–0.54)
Manhattan 1,580 3.18 Referent 314 4.91 Referent
Queens 380 0.60 0.24 (0.19–0.29) 103 1.05 0.29 (0.21–0.41)
Staten Island
 51
 0.46
 0.55 (0.38–0.80)
8
 0.43
 0.30 (0.13–0.66)
Race/ethnicity‡
Hispanic 969 1.45 1.16 (0.96–1.40) 194 1.96 0.76 (0.56–1.04)
Non-Hispanic white 1,067 1.18 Referent 310 2.47 Referent
Non-Hispanic black/African American 855 1.77 1.45 (1.20–1.75) 122 1.54 0.65 (0.46–0.91)
Other
 161
 0.68
 0.79 (0.61–1.03)
77
 1.39
 0.69 (0.47–1.01)
Immune status†‡
Non-HIV/AIDS 1,349 0.65 Referent 544 1.56 Referent
HIV/AIDS
 1,863
 55.6
 89.0 (70.2–112.3)
190
 39.0
 23.30 (16.4–33.2)
Neighborhood poverty‡§
Low 883 1.18 Referent 203 2.10 Referent
Medium 769 1.56 1.03 (0.86–1.25) 197 1.97 0.86 (0.61–1.17)
High 583 1.46 1.23 (1.01–1.49) 151 2.16 0.97 (0.69–1.35)
Very high 917 1.87 1.42 (1.18–1.70) 188 2.45 1.17 (0.85–1.62)

*Incidence is median no. cases/100,000 persons; ACS, American Community Survey; IRR, incidence rate ratio.
†Incidence and IRR not age-adjusted.
‡All categories had <10 missing values with the exception of race/ethnicity during 2000─2014 (n = 192) and 2015─2018 (n = 37), immune status during 2000─2014 (n = 32), and poverty during 2000─2014 (n = 92).
§Classified by percent of census tract residents living below the federal poverty line (low, <10%; medium, 10%–<20%; high, 20%–<30%; very high, >30%); population denominator data were as follows for each listed year: 2000─2004 (2000 US Census); 2005─2009 (ACS 2007–2011); 2010 (2010 Census); 2011 (ACS 2009─2013); 2012 (ACS 2010─2014); 2013 (ACS 2011─2015); 2014─2018 (ACS 2012─2016).

Main Article

1Preliminary results were presented at the annual meeting of the Council of State and Territorial Epidemiologists, June 11–13, 2018; West Palm Beach, Florida, USA.

2Current affiliation: Los Angeles County Department of Health, Los Angeles, California, USA.

3Current affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Page created: February 19, 2020
Page updated: February 19, 2020
Page reviewed: February 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external